Thursday, January 21, 2010

Featured physician executive: David S. Tierney, M.D.

This week's featured physician executive is David S. Tierney, M.D.

David S. Tierney, MD, is President and Chief Operating Officer of Oceana Therapeutics, Inc. Previously, Dr. Tierney was the President, Chief Executive Officer and a director of Valera Pharmaceuticals, Inc., until it was acquired by Indevus Pharmaceuticals, Inc., in April 2007. From January 2000 to August 2000, Dr. Tierney served as President of Biovail Technologies, a division of Biovail Corporation, a Canadian drug delivery company, where he had responsibility for all of Biovail's research and development and regulatory and clinical activities. From March 1997 to January 2000, Dr. Tierney was Senior Vice President of Drug Development at Roberts Phar­ma­ceu­ti­cal Corporation, with responsibility for all research and development ac­tiv­i­ties, and overall responsibility for drug development, medical affairs, world­wide regulatory affairs and chemical process development, as well as being part of the executive management team. From December 1989 to March 1997, Dr. Tierney was at √Član Corporation in a variety of management positions. Dr. Tierney received his medical degree from the Royal College of Surgeons in Dublin, Ireland, and subsequently trained in internal medicine.

No comments:

Post a Comment